Navigation Links
InterMune Reports Results from Triple Combination Study of ITMN-191
Date:1/12/2009

(SOC) and none led to treatment discontinuation.

Only four Grade 3 AEs were reported during study treatment, two of which (sciatica and back pain) were deemed by the investigator to be unrelated to ITMN-191. The other two were neutropenia and indirect bilirubin elevation. Neutropenia occurred with a similar pattern, frequency and severity in the placebo and ITMN-191 groups. Minor and transient elevations in indirect bilirubin levels were observed in a small number of placebo and ITMN-191 patients and were deemed not clinically significant by the investigator. There were no other laboratory or ECG findings during study treatment that were attributable to ITMN-191.


           Summary of Viral Kinetic Assessments Following 14 Days of Treatment


                            Median Change
                             HCV RNA at
                            EOT(1),(2)           BLQ           BLD
                               Log10         (<25 IU/mL)  (<9.3 IU/mL)
          Dose        N       (IU/mL)            (%)           (%)

         Placebo      12        -2.2           1/12 (8%)     0/12 (0%)
       100 mg q8h      8        -5.5           6/8 (75%)     1/8 (13%)
       200 mg q8h      8        -5.7           7/8 (88%)     4/8 (50%)
       300 mg q8h      7        -5.6           5/7 (71%)     4/7 (57%)
       400 mg q12h     7        -4.7           4/7 (57%)     1/7 (14%)
       600 mg q12h     8        -5.4           6/8 (75%)     1/8 (13%)
       900 mg q12h     7        -5.3           4/7 (57%)     1/7 (14%)

      (1)  EOT = End of Treatment
      (2)  Values below Limit of Quantification (LOQ) of 25 IU/mL were
           assigned value of 1.236 log10;   values below Limit of Detection
           (LOD) of 9.3 IU/mL were assigned value of 0.667 log10

A chart of the median log10 HCV RNA changes from baseline to Day 14 for each dose cohort is available on the
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. InterMune to Present at Thomas Weisel Partners Healthcare Conference
2. Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations
3. InterMune to Present at the 2008 Wachovia Healthcare Conference
4. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
5. LegalView Reports Traumatic Brain Injury Study Concluding Spirituality Increases Following Brain Damage
6. Allscripts Reports Fiscal 2009 Second Quarter Results
7. MDS Reports Final Fourth-Quarter 2008 Results
8. Consumer Reports: Big Promises of Some Infomercial Exercise Machines Fall Flat; Plus, Set Up a Home Gym for Under $100
9. Cardium Reports on Exchange Listing With NYSE Alternext US
10. CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte Closes
11. Joint Commission Reports Positive Survey Results for CHA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... Dennis Thompson HealthDay ... A newborn,s risk of developing celiac disease isn,t reduced by ... in wheat called gluten to an infant,s diet help prevent ... pair of new studies in the Oct. 2 New ... to rest hopes that a child could avoid celiac disease ...
(Date:10/2/2014)... discovery by scientists at The University of Nottingham could ... of painkiller. , A drug resulting from the research, ... would offer new hope to sufferers of chronic pain ... effective painkillers are currently available. , The work, led ... Life Sciences, in collaboration with David Bates, Professor of ...
(Date:10/1/2014)... new research study published today in the Journal ... patients older than 50 years with moderate or severe ... , Researchers from the University of Melbourne randomly assigned ... pain to no acupuncture or sham or pretend laser ... with participants and acupuncturists blinded to laser and sham ...
(Date:10/1/2014)... Despite a policy focus on expanding access to ... population continues to have significant dental disease. In ... the American Dental Association , researchers from Tufts ... of Dental Medicine report on the first large-scale ... provided by caregivers to adults with developmental disabilities. ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Insuranceragents.info ... find a good life insurance plan for vulnerable family ... for vulnerable family members. Providers in the family should ... will cause financial hardships for the rest of the ... of policies. Families can benefit more from temporary coverage ...
Breaking Medicine News(10 mins):Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 2Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 3Health News:Medical discovery first step on path to new painkillers 2Health News:Study finds acupuncture does not improve chronic knee pain 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2
... - Scientists at the Toronto Western Research Institute (TWRI), ... the brain against the damaging effects of a stroke ... development for a few years. At this point, it ... drugs created to reduce the brain,s vulnerability to stroke ...
... sudden urge to urinate, affects the quality of life of ... respond to or can tolerate oral medications and may benefit ... of Rhode Island is conducting a study to compare the ... urge incontinence after trying other treatments. Patients are currently ...
... there,s hope. In the March 2012 print issue of ... the University of Florida report that a family of ... role in the regulation of skeletal muscle mass. Specifically, ... transcription factors prevents muscle wasting associated with cancer and ...
... , This release is available in French ... University of Montreal and CHUM Hospital,s International Health, will be ... be working on the funding of the fight against Noma. ... of children mostly in Sub-Saharan Africa. Despite the existence of ...
... , TUESDAY, Feb. 28 (HealthDay News) -- Poor people ... more money are, a new study shows. This finding ... otherwise due to an "unconscious bias" they have against low-income ... Monterey Orthopaedic and Sports Medicine Institute in California, and colleagues. ...
... -- Researchers who used family trees dating back to ... inherited heart rhythm disorders say their findings can help ... with these disorders. Sudden cardiac death can occur ... Genetic testing can identify people with an inherited heart ...
Cached Medicine News:Health News:Canadian scientist develops world's most advanced drug to protect the brain after a stroke 2Health News:Women & Infants studying therapies to relieve urinary urge incontinence 2Health News:No workout? No worries: Scientists prevent muscle loss in mice, despite disease and inactivity 2Health News:Montrealer heads to Congo to fight childhood disfigurement 2Health News:Poor Patients Less Likely to Sue Doctors, Analysis Shows 2Health News:Family Tree May Aid Treatment of Inherited Heart Disorders 2
(Date:10/2/2014)... 2014  MinuteClinic, the largest and fastest growing provider of retail ... opened its first walk-in clinics in the Corpus Christi ... Corpus Christi and Portland . A ... in December. The clinics are part of MinuteClinic,s national ... the Corpus Christi -area openings, there are now ...
(Date:10/2/2014)... 2, 2014  AxelaCare Health Solutions, www.axelacare.com , ... today that it has acquired Advanced Care, a ... provider.  Terms of the transaction were not disclosed. ... solutions pharmacies to 18 nationwide and expands AxelaCare,s national ... York - New Jersey metro ...
(Date:10/2/2014)... --  Mast Therapeutics, Inc. (NYSE MKT: MSTX), a ... Parsley , D.O. has joined the Company as its ... Dr. Parsley has been actively engaged with the Company ... He has served as Mast,s interim Chief Medical Officer ... Aires since April 2011.  Dr. Parsley previously was with ...
Breaking Medicine Technology:First MinuteClinic Walk-in Medical Clinics Open in Corpus Christi 2First MinuteClinic Walk-in Medical Clinics Open in Corpus Christi 3AxelaCare Health Solutions Acquires Advanced Care of New York 2AxelaCare Health Solutions Acquires Advanced Care of New York 3Mast Therapeutics Announces Appointment Of Chief Medical Officer 2Mast Therapeutics Announces Appointment Of Chief Medical Officer 3Mast Therapeutics Announces Appointment Of Chief Medical Officer 4
... Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ... development, assembly, marketing and sale of medical devices and ... will participate in the MEDICA 2010 International Trade Fair, ... Fairgrounds in Dusseldorf, Germany. More than ...
... 2010 BioSpecifics Technologies Corp. (Nasdaq: BSTC ... products, today announced that BioSpecifics, President, Tom Wegman, will ... Healthcare Conference on Wednesday, November 17, 2010, at 2:45 ... New York. A live webcast of the ...
Cached Medicine Technology:Dehaier Medical to Participate in MEDICA International Trade Fair 2Dehaier Medical to Participate in MEDICA International Trade Fair 3
... cup system has been designed to enhance ... and cluster hole configurations. The objective of ... on three primary modes: Tilt, migration and ... result in initial and long-term fixation. The ...
Optimal solution for normal acetabulum and younger patients....
Biopro rimmed acetabular is manufactured from titanium and is porous coated on the outside of its shell. The rimmed acetabular accommodates a polyethylene inert....
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
Medicine Products: